Xuchang KETOP Testing Research Institute Co.,Ltd

SZSE:003008.SZ

25.64 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 54.67561.88644.67759.11645.86946.97338.86844.83536.59244.04830.50944.91530.80532.89435.28245.75534.08757.83427.8136.35851.74732.49982.24
Cost of Revenue 18.89620.27315.91918.79216.48516.5512.60712.33412.71711.95910.09815.55510.0710.2259.56625.1388.519.1017.910.73710.2899.01710.915
Gross Profit 35.77841.61328.75840.32429.38330.42226.26132.50123.87432.08920.41129.35920.73522.66925.71520.61725.57748.73319.9125.62141.45823.48271.324
Gross Profit Ratio 0.6540.6720.6440.6820.6410.6480.6760.7250.6520.7290.6690.6540.6730.6890.7290.4510.750.8430.7160.7050.8010.7230.867
Reseach & Development Expenses 2.4721.5142.4293.342.9042.9252.6092.7782.5472.8272.4453.6052.7221.9011.7914.6081.6361.3231.6073.8942.5022.7381.615
General & Administrative Expenses 15.8870.6097.777-14.32421.198-6.12910.184-9.20413.086-3.0425.128-4.9089.524-0.9773.734-3.7623.2990.7850.638-8.9934.5914.7383.943
Selling & Marketing Expenses 5.0642.5672.6952.812.9672.2642.3011.8371.6942.7041.4852.6442.2471.3071.2783.0031.3371.4161.1441.6451.6922.3371.43
SG&A 20.9517.58810.473-11.51424.165-3.86412.485-7.36714.78-0.3386.613-2.26411.7720.335.012-0.7584.6362.2021.783-7.3476.2837.0755.373
Other Expenses -9.1470.0090.025-32.757-0.110.0040.5619.407-7.5247.7690.234-0.550.237-0.080.090.9781.5220.0050.0680.5020.0670.174-0
Operating Expenses 14.2779.09413.73432.75713.89513.67615.65314.8189.80310.2579.29314.5519.1648.2416.74316.5476.5816.4835.42110.9279.18810.2247.384
Operating Income 23.50132.51919.2426.35818.79419.36414.89720.635.97625.62610.96318.21315.97218.64622.7186.44619.6642.61414.65715.64832.51914.11563.798
Operating Income Ratio 0.430.5250.4310.4460.410.4120.3830.460.1630.5820.3590.4060.5180.5670.6440.1410.5770.7370.5270.430.6280.4340.776
Total Other Income Expenses Net -0.0893.6640.0250.35-0.110.0045.004-0.27913.1310.254.73-0.554.6384.1383.8373.3542.1860.3690.2351.4560.3161.03-0.142
Income Before Tax 23.41236.18319.26626.70918.68419.36819.90120.35119.10725.87615.69317.66316.20918.56622.8097.42421.18242.61914.72516.1532.58614.28963.798
Income Before Tax Ratio 0.4280.5850.4310.4520.4070.4120.5120.4540.5220.5870.5140.3930.5260.5640.6460.1620.6210.7370.5290.4440.630.440.776
Income Tax Expense 6.75610.0896.1544.4663.5263.7793.8433.3712.7173.7142.2162.3252.4182.8253.4270.813.0435.6772.162.3154.6162.1519.525
Net Income 16.65626.2113.11222.24315.15815.58916.05716.9816.3922.16213.47615.33813.79115.74119.3816.61318.1436.94212.56513.83527.9712.13854.273
Net Income Ratio 0.3050.4240.2930.3760.330.3320.4130.3790.4480.5030.4420.3410.4480.4790.5490.1450.5320.6390.4520.3810.5410.3730.66
EPS 0.160.250.160.280.190.190.20.210.210.280.170.150.170.190.240.110.290.620.210.230.470.20.91
EPS Diluted 0.160.250.160.280.190.190.20.210.210.280.170.140.170.190.240.110.290.620.210.230.470.20.91
EBITDA 23.41845.72119.07230.02517.28617.65220.217346.64529.43511.57129.62413.66613.2318.4063.57918.87650.17722.13214.19532.54513.00871.395
EBITDA Ratio 0.4280.7390.4270.5080.3770.3760.520.7580.1820.6680.3790.660.4440.4020.5220.0780.5540.8680.7960.390.6290.40.868